SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pluristem Therapeutics
PSTI 8.720+0.2%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: xcentral110/5/2009 10:45:19 AM
   of 295
 
It would be remiss not to post this news...
but remember:
(for as long as I have been following them)
Every time PSTI has needed funding, the Israeli Gov't has given them whatever they have needed.. so ....

Pluristem Provides Disclosure Pursuant to NASDAQ Marketplace Rule 5250(b)(2)

HAIFA, Israel, Oct 1, 2009 (GlobeNewswire via COMTEX) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced, that on September 23, 2009, it filed its Annual Report on Form 10-K with the SEC, which included an audit report by the company's independent registered public accounting firm containing a going concern qualification. The company makes this announcement in compliance with NASDAQ Marketplace Rule 5250(b)(2). The company's auditors had previously issued going concern opinions for its fiscal years 2008, 2007 and 2006, in addition to several prior years.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext